In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zur Rose’s European playpen

This article is powered by OTC Bulletin & The Rose Sheet

Executive Summary

As Switzerland-based e-commerce pharmacy Zur Rose goes from strength to strength, David Ridley talks to the company’s chief executive officer, Walter Oberhänsli, about his firm’s latest experiments in European OTC market disruption.


Related Content

OTC Vending Machines? Meet Zur Rose’s Latest Experiment In Automated Pharmacy
Zur Rose’s Experiment In Automated Pharmacy Shut Down For A Second Time
Functional Nutrition Opens Door To New European Online OTC Market Opportunities For Shop Apotheke
France And Italy Next For Zur Rose As Sales Exceed $1bn For First Time





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts